Molecular Predictors of Risk and Clinical Outcome in Patients with Bladder Cancer

Contact: Xifeng Wu, M.D., Ph.D.

Number of Enrolled Cancer Patients/Survivors:	2,401
Years of Diagnoses of Enrolled Cancer Patients/Survivors:	1997-present
Approximate Years of Follow-up:	14 years (the longest)
Cancer Sites Represented:	Bladder
Biological Specimens Collected:	Blood/Blood Fraction Urine
Treatment Outcome Measures:	Physician/Medical Record Reported Symptom Assessment Acute Medical Event Late Medical Event Cancer Recurrence Death Patient-Reported Symptom Assessment Quality of Life Cancer Recurrence
Co-morbidities at Study Entry:	Diabetes Heart Disease Pulmonary Disease Other
Lifestyle Factors:	Smoking Alcohol Use Diet Physical Activity Body Mass Index Weight Loss/Control Other
Treatment Data:	Surgery Radiation Chemotherapy Hormonal Therapy Bone Marrow/Stem Cell Transplant
Treatment Data Assessed By:	Electronic Record Chart Abstraction Patient Reported Questionnaire
Is the study open to collaboration?	Yes